About KARIUS, INC.
Karius is a company specializing in advanced metagenomic infectious disease diagnostics, using genomic and AI technologies to detect pathogens through microbial cell-free DNA analysis. The company collaborates with institutions like Mayo Clinic Laboratories to expand diagnostic access.
Clinical metagenomics for infectious disease diagnosticsDetection of microbial cell-free DNA (mcfDNA) from pathogensAI-driven analysis of genomic data in real timeMetagenomic sequencing tests for rapid and comprehensive pathogen detectionBlood and bronchoalveolar lavage (BAL) fluid-based testing
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $250K | |
| Federal contract award | Department of Defense | $240K | |
| KARIUS NEXT GENERATION SEQUENCING TEST $2,000.00 PER TEST | Department of Veterans Affairs | $120K | |
| KARIUS NEXT GENERATION SEQUENCING TEST $2,000.00 PER TEST | Department of Veterans Affairs | $60K | |
| KARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DET | Department of Health and Human Services | $631K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KARIUS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.